Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness

I Mindlin1, R Herzog2, L Belloli2,3

  • 1Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris, 75013, France. ivan.mindlin@icm-institute.org.

Communications Biology
|September 19, 2024
PubMed

Insights

New research uses brain models and AI to explore treatments for disorders of consciousness (DoC). Serotonin and opioid receptor activation showed potential for improving brain dynamics in DoC models.

Area of Science:

  • Neuroscience
  • Computational Psychiatry
  • Pharmacology

Background:

  • Disorders of consciousness (DoC) present significant challenges in diagnosis and treatment.
  • Current therapeutic options for DoC are limited, necessitating novel approaches.
  • Ethical and methodological constraints hinder direct clinical investigation of new treatments for DoC.

Purpose of the Study:

  • To develop and validate a computational framework for studying DoC.
  • To investigate the potential of pharmacological interventions for DoC using computational models.
  • To explore the mechanisms underlying consciousness disorders and potential therapeutic targets.

Main Methods:

  • Utilized biologically plausible whole-brain models integrated with deep learning techniques.
  • Characterized the low-dimensional dynamical space of patients with disorders of consciousness.
  • Simulated pharmacological interventions by modeling the effects of enhanced neurotransmitter levels on brain dynamics.

Main Results:

  • Serotonergic and opioid receptor activation shifted DoC models towards healthier dynamical states.
  • Improvements in DoC models correlated with the density of activated receptors.
  • The study identified specific receptor pathways with therapeutic potential for DoC.

Conclusions:

  • Computational modeling offers a viable method to explore DoC treatments within ethical and methodological boundaries.
  • Pharmacological interventions targeting serotonergic and opioid systems show promise for DoC.
  • This approach could advance treatments for a range of brain disorders beyond DoC.